<-- Back to proposed bills
Covid-19 Update
12 January 2022
Type
Written Ministerial Statement
Department
Department of Health and Social Care
At a Glance
Issue Summary
The statement provides an update on the progress of the PANORAMIC study for evaluating new antivirals against COVID-19, particularly focusing on molnupiravir.
Action Requested
MPs are requested to encourage their constituents to participate in the PANORAMIC trial by signing up online or through a freephone number. The Department will publish further updates as more data becomes available.
Key Facts
- The PANORAMIC study was launched on 8 December 2021.
- Recruitment of 3,176 participants has been achieved as of noon on 12 January 2022.
- Participants must be over 50 years old or over 18 with certain underlying health conditions and have received a positive test for COVID-19 within the last five days.
- Molnupiravir was granted conditional Marketing Authorisation by the Medicines and Healthcare products Regulatory Agency on 4 November 2021.
▸
Assessment & feedback
Summary accuracy